Today: 17.Oct.2017

European Association of Nuclear Medicine: Many people associate the term, nuclear medicine, with dangerous radiation. These concerns are unfounded. While it is true that radioactive substances are used, the exposure doses to the patient are so low according to the European Association of Nuclear Medicine (EANM) that they do not call into question the benefits of the diagnostic and therapeutic possibilities of nuclear medicine.

Jane Orient, M.D., managing editor of the Journal of American Physicians and Surgeons, Bobby Scott, scientist emeritus at Lovelace Respiratory Research Institute, William Briggs, Adjunct Professor of Statistics at Cornell, Hermann W. Berg, M.D.: “Science” is said to be dictating “evidence-based” policy with far-reaching effects on American life. “Evidence-based medicine,” which is largely applied epidemiology, supports the “guidelines” that increasingly dictate medical treatment. Its flaws are so serious that even its former ardent proponents are beginning to recognize that it is in crisis,

Published in Low Dose Radiation

Bobby Scott, scientist emeritus at Lovelace Respiratory Research Institute, Albuquerque, NM: Findings reported here point out the lack of any solid evidence for cancer induction by low radiation doses (< 100 mGy) such as are received from single or several applications of CT or chest X-rays. Particularly disturbing is the application of the Linear No-Threshold model. The notion that multiple uses of diagnostic imaging, when separated by weeks or months or longer, is cumulative with respect to damage induction, is not supported by the fact that lifetime exposure to ionizing radiation in regions of elevated background radiation does not increase cancer risk. The claims of harm from such exposures are based mainly on seriously flawed epidemiological studies that usually rely on the unscientific and forced LNT default model.

Published in Low Dose Radiation

Dario Jinchuk - Excellent summary of nuclear power, nuclear technology and nuclear science in Argentina.

Newsletter Subscription

  • Latest
  • Popular
  • Michael Shellenberger, Environmental Progress: Since the Fukushima…
  • Clinton Crackel, Co-founder and Co-chairman Nuclear Fuels…
  • Clinton Crackel, Co-founder and Co-chairman Nuclear Fuels…
  • Walter Horsting, Principal Business Development International: The…
  • Paul Driessen, senior policy analyst for the…
  • Clinton Crackel, Co-founder and Co-chairman Nuclear Fuels…
  • Walter Horsting, Principal Business Development International: The…
  • Michael Shellenberger, Environmental Progress: Since the Fukushima…